Significantly fewer patients in the fluocinolone acetonide intravitreal implant group experienced recurrence of uveitis at 6 months compared with the sham group. The Food and Drug Administration (FDA) ...
ANI Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for ILUVIEN, a fluocinolone acetonide intravitreal implant, allowing it to be used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results